New England Invests $1.4 Billion in Fourth-Quarter 2016 Life Science Construction Starts
New England Invests $1.4 Billion in Fourth-Quarter 2016 Life Science Construction Starts
Attachment: Pharma-Biotech New England Kickoffs 4Q16
SUGAR LAND--November 8, 2016--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--It may be getting chilly in New England, but the life science industry continues to heat up the region with major capital investment. According to a recent analysis of Industrial Info's Pharmaceutical-Biotech Industry platform, the New England region is set to launch 15 projects, with a total investment value (TIV) of $1.4 billion, before the end of the year. The region has long been a favorite of the industry, hosting an impressive roster of the top biotech and pharmaceutical companies, along with nascent but promising start-ups.
Within this article: Details on some of the top-valued pharma and biotech projects set to begin construction in the New England region in the final quarter of 2016.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- EU Adds New COVID-19 Manufacturing Capacity
- Design, Consulting Firm Stantec at Work at More Than $50 Billion in Project...
- Turner Construction at Work on Projects Valued at $9.8 Billion
- Pharma-Biotech Industry Helps Drive $14.4 Billion Industrial Project Activi...
- Ørsted Completes U.S. Offshore Windfarm, Divests Stake in Onshore Wind Asse...